ToleroTech is an emerging biotechnological company that is in the business of developing and commercializing medical products based on proprietary RNA interference technology and expertise. The founder Dr Wei-Ping Min is affiliated with Lawson Health Research Institute and University of Western Ontario. Our technologies focus on using siRNA to treat immune-associate diseases, such as cancer, autoimmune diseases, allergy, and transplant rejection.
- Autoimmune Diseases
- Allergy
- Cancer
- Transplantation Rejection
- Organ preservation
- Validation of technology in pre-clinical models
- Seek strategic partners for drug development
- Clinical trials and regulatory approval